A Tale Of Two Advisory Panels: The Divergent Fates Of Pretomanid And Plazomicin

 
• By Michael Cipriano
  
view of three wooden directional signs on a pole - Image
Panelists went in different directions when voting on approval for the two drugs.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers